sellWeak10b5-1 plan
David F Novack sold $465k of DVAX
President & COO at DYNAVAX TECHNOLOGIES CORP. 30,000 shares at an average of $15.49, traded Dec 24, 2025, filed Dec 29, 2025.
Warning score
7Value
$465k
30,000 shares
Holdings after
111,451
-21% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RolePresident
- +17Trade size$465k at market
- +5Share of holdings soldSold 21% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-25-058985, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | AGrant or award Common Stock | +60,625 | - | - | 70,043 | Dec 29, 2025 |
| Dec 23, 2025 | MOption exercise Common Stock | +22,620 | - | - | 92,663 | Dec 29, 2025 |
| Dec 23, 2025 | MOption exercise Common Stock | +18,788 | - | - | 111,451 | Dec 29, 2025 |
| Dec 24, 2025 | MOption exercise Common Stock10b5-1 | +20,000 | $6.81 | $136k | 131,451 | Dec 29, 2025 |
| Dec 24, 2025 | MOption exercise Common Stock10b5-1 | +10,000 | $10.47 | $105k | 141,451 | Dec 29, 2025 |
| Dec 24, 2025 | SOpen-market sale Common Stock10b5-1 | -30,000 | $15.49 | $465k | 111,451 | Dec 29, 2025 |
| Dec 24, 2025 | FTax withholding Common Stock | -48,107 | $15.38 | $740k | 63,344 | Dec 29, 2025 |
| Dec 23, 2025 | MOption exercise Restricted Stock Unitderivative | -22,620 | - | - | 22,620 | Dec 29, 2025 |
| Dec 23, 2025 | MOption exercise Restricted Stock Unitderivative | -18,788 | - | - | 37,576 | Dec 29, 2025 |
| Dec 24, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | - | - | 166,528 | Dec 29, 2025 |
| Dec 24, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | - | - | 85,655 | Dec 29, 2025 |
Related signals
Other insiders at DYNAVAX TECHNOLOGIES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $1.8M 114,000 shares | -64% | |
| 24Weak | DVAXbuy DYNAVAX TECHNOLOGIES CORP | Scott Dunseth Myers director | $41k 3,800 shares | +12% | |
| 42Moderate | DVAXsell DYNAVAX TECHNOLOGIES CORP | Deep Track Biotechnology Master Fund, Ltd. owner | $22M 2,065,137 shares | -12% | |
| 16Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $140k 10,000 shares | -55% | |
| 32Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $190k 14,020 shares | -63% | |
| 37Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $471k 32,764 shares | -60% | |
| 21Weak | DVAXsell DYNAVAX TECHNOLOGIES CORP | Francis Cano director | $43k 3,615 shares | -9% | |
| 33Weak | DVAXsell DYNAVAX TECHNOLOGIES CORP | Justin Burgess Chief Accounting Officer | $262k 20,526 shares | -100% | |
| 0Weak | DYNAVAX TECHNOLOGIES CORP | Robert Janssen SVP and CMO | $23k 1,500 shares | -3% | |
| 24Weak | DYNAVAX TECHNOLOGIES CORP | David F Novack President & COO | $130k 9,000 shares | -74% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.